vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and Greenlane Holdings, Inc. (GNLN). Click either name above to swap in a different company.

ASP Isotopes Inc. is the larger business by last-quarter revenue ($16.7M vs $10.0M, roughly 1.7× Greenlane Holdings, Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs -54.5%). Greenlane Holdings, Inc. produced more free cash flow last quarter ($-3.4M vs $-47.4M).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

Greenlane Holdings, Inc. is a leading global distributor of premium consumption accessories, wellness products, and lifestyle goods catering to the cannabis, vaping, and natural health sectors. It serves retail partners, brand manufacturers, and end consumers across North America and select international markets, providing end-to-end supply chain, brand development, and integrated sales support services.

ASPI vs GNLN — Head-to-Head

Bigger by revenue
ASPI
ASPI
1.7× larger
ASPI
$16.7M
$10.0M
GNLN
Growing faster (revenue YoY)
ASPI
ASPI
+1350.2% gap
ASPI
1295.7%
-54.5%
GNLN
More free cash flow
GNLN
GNLN
$44.1M more FCF
GNLN
$-3.4M
$-47.4M
ASPI

Income Statement — Q4 FY2025 vs Q4 FY2023

Metric
ASPI
ASPI
GNLN
GNLN
Revenue
$16.7M
$10.0M
Net Profit
$-4.3M
Gross Margin
12.5%
46.1%
Operating Margin
-31.5%
Net Margin
-43.4%
Revenue YoY
1295.7%
-54.5%
Net Profit YoY
-586.8%
62.5%
EPS (diluted)
$61.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
GNLN
GNLN
Q4 25
$16.7M
Q3 25
$4.9M
Q4 23
$10.0M
Q3 23
$11.8M
Q2 23
$19.6M
Q1 23
$24.0M
Q4 22
$22.0M
Q3 22
$28.7M
Net Profit
ASPI
ASPI
GNLN
GNLN
Q4 25
Q3 25
$-12.9M
Q4 23
$-4.3M
Q3 23
$-10.1M
Q2 23
$-9.0M
Q1 23
$-8.7M
Q4 22
$-11.6M
Q3 22
$-130.5M
Gross Margin
ASPI
ASPI
GNLN
GNLN
Q4 25
12.5%
Q3 25
8.7%
Q4 23
46.1%
Q3 23
26.5%
Q2 23
23.3%
Q1 23
23.0%
Q4 22
27.1%
Q3 22
17.3%
Operating Margin
ASPI
ASPI
GNLN
GNLN
Q4 25
Q3 25
-306.1%
Q4 23
-31.5%
Q3 23
-58.4%
Q2 23
-40.9%
Q1 23
-33.5%
Q4 22
-67.1%
Q3 22
-479.4%
Net Margin
ASPI
ASPI
GNLN
GNLN
Q4 25
Q3 25
-263.7%
Q4 23
-43.4%
Q3 23
-85.7%
Q2 23
-46.0%
Q1 23
-36.3%
Q4 22
-52.6%
Q3 22
-455.0%
EPS (diluted)
ASPI
ASPI
GNLN
GNLN
Q4 25
Q3 25
$-0.15
Q4 23
$61.48
Q3 23
$-1.91
Q2 23
$-62.29
Q1 23
$-5.44
Q4 22
$202.10
Q3 22
$-198.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
GNLN
GNLN
Cash + ST InvestmentsLiquidity on hand
$333.3M
$463.0K
Total DebtLower is stronger
$14.4M
$7.3M
Stockholders' EquityBook value
$204.2M
$11.1M
Total Assets
$498.0M
$38.1M
Debt / EquityLower = less leverage
0.07×
0.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
GNLN
GNLN
Q4 25
$333.3M
Q3 25
$113.9M
Q4 23
$463.0K
Q3 23
$2.4M
Q2 23
$4.7M
Q1 23
$5.9M
Q4 22
$6.5M
Q3 22
$8.0M
Total Debt
ASPI
ASPI
GNLN
GNLN
Q4 25
$14.4M
Q3 25
$13.9M
Q4 23
$7.3M
Q3 23
Q2 23
Q1 23
$10.7M
Q4 22
$18.2M
Q3 22
$18.8M
Stockholders' Equity
ASPI
ASPI
GNLN
GNLN
Q4 25
$204.2M
Q3 25
$74.1M
Q4 23
$11.1M
Q3 23
$15.4M
Q2 23
$21.7M
Q1 23
$30.7M
Q4 22
$39.0M
Q3 22
$45.9M
Total Assets
ASPI
ASPI
GNLN
GNLN
Q4 25
$498.0M
Q3 25
$225.9M
Q4 23
$38.1M
Q3 23
$48.4M
Q2 23
$61.1M
Q1 23
$75.1M
Q4 22
$89.7M
Q3 22
$107.3M
Debt / Equity
ASPI
ASPI
GNLN
GNLN
Q4 25
0.07×
Q3 25
0.19×
Q4 23
0.65×
Q3 23
Q2 23
Q1 23
0.35×
Q4 22
0.47×
Q3 22
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
GNLN
GNLN
Operating Cash FlowLast quarter
$-37.8M
$-3.0M
Free Cash FlowOCF − Capex
$-47.4M
$-3.4M
FCF MarginFCF / Revenue
-284.7%
-33.6%
Capex IntensityCapex / Revenue
57.9%
3.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
GNLN
GNLN
Q4 25
$-37.8M
Q3 25
$-8.9M
Q4 23
$-3.0M
Q3 23
$-3.5M
Q2 23
$2.8M
Q1 23
$1.9M
Q4 22
$-3.9M
Q3 22
$-8.8M
Free Cash Flow
ASPI
ASPI
GNLN
GNLN
Q4 25
$-47.4M
Q3 25
$-12.0M
Q4 23
$-3.4M
Q3 23
$-3.8M
Q2 23
$2.6M
Q1 23
$1.7M
Q4 22
$-5.1M
Q3 22
$-9.1M
FCF Margin
ASPI
ASPI
GNLN
GNLN
Q4 25
-284.7%
Q3 25
-245.5%
Q4 23
-33.6%
Q3 23
-32.1%
Q2 23
13.5%
Q1 23
7.1%
Q4 22
-23.1%
Q3 22
-31.9%
Capex Intensity
ASPI
ASPI
GNLN
GNLN
Q4 25
57.9%
Q3 25
64.4%
Q4 23
3.7%
Q3 23
2.8%
Q2 23
0.7%
Q1 23
0.7%
Q4 22
5.1%
Q3 22
1.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons